Abstract
Morphological studies of pancreatic cancers do not provide sufficient information to predict their biological behavior. The study of genetic abnormalities in pancreatic cancers may open new paths for understanding the etiology and pathogenesis of the disease, and may help in establishing markers for diagnosis and prognosis. There is increasing evidence that it is the accumulation of different genetic abnormalities, rather than a single gene defect, that underlies the multistage processes of tumorigenesis and progression of malignancy [1]. Growth factors and their receptors, tumor suppressor genes, and oncogenes have received considerable attention and seem to be promising in assessing of malignant potential [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marx J (1989) Research news: Many gene changes found in cancer. Science 246: 1386–1388
Lemoine NR, Hall PA (1990) Oncogenes and growth factors in pancreatic cancer. Bailliere’s Clin Gastroenterol 4: 815–832
Lemoine NR, Hughes CM, Barton CM (1992) The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166: 7–12
Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR (1991) Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163: 111–116
Glinsmann-Gibson BJ, Korc M (1991) Regulation of transforming growth factor alpha mRNA expression in T3M4 human pancreatic carcinoma cells. Pancreas 6: 142–149
Henry JA, Bennett MK, Piggott NH, Levett DL, May FEB, Westley BR (1991) Expression of the pNR2/pS2 protein in diverse human epithelial tumors. Br J Cancer 64: 677–682 21.
Welter C, Theisinger B, Seitz G (1992) Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 66:187–192
Williams TM, Weiner DB, Greene MI, Maguire HC (1991) Expression of c-erbB-2 in human pancreatic adenocarcinomas. Pathobiol 59: 46–52
Lemoine NR, Lobresco M, Leung HY, Barton CM, Prigent SA, Gullick WJ, Klöppel G (1992) The ERBB3 proto-oncogene in human pancreatic cancer. J Pathol 168: 269–273
Ding SF, Habib NA, Delhanty JDA (1992) Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas. Br J Cancer 65: 809–812
Neuman WL, Wasylyshyn ML, Jacoby R (1991) Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes, Chromosomes Cancer 3: 468–473
Barton CM, Staddon SL, Hughes CM (1991) Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer 64: 1076–1082
Hall PA, Ray A, Lemoine NR, Midgley CM, Krausz T, Lane DP (1991) Diagnostic utility of p53 immunostaining in cytopathology. Lancet 338: 513
Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Klöppel G (1992) Ki-ras oncogene activation in pre-invasive pancreatic cancer. Gastroenterology 101: 230–236
Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H (1991) Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 214: 657–662
Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T (1991) Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 86: 1784–1788
Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Lacono C, Hirohashi S (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142: 1534–1543
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 Mutations in human cancers. Science 253: 49–53
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879
Suzuki Y, Sekiya T, Hayashi K (1991) Allele-specific polymerase chain reaction: A method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 192: 82–84
Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant cK-ras genes. Cell 53: 549–554
Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H (1990) Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer (in Japanese). Jpn J Cancer Res 81: 135–140
Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S (1989) Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 80: 622–626
Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL (1988) K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16: 7773–7782
Grünewald K, Lyons J, Frehlich A, Feichtinger H, Weger RA, Schwab G, Janssen JWG, Bartram CR (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43: 1037–1041
Gonzales-Cadavid NF, Zhou D, Battifora H, Bar-Eli M, Cline MJ (1989) Direct sequencing analysis of exon 1 of the c-Ki-ras gene shows a low frequency of mutations in human pancreatic carcinomas. Oncogene 4: 1137–1 140
Banks L, Matlashewski G, Crawford L (1986) Isolation of human p53 monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159: 529–534
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238
Vogelstein B, Kinzler KW (1992) Carcinogens leave fingerprints. Nature 355: 209–210
Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove MM, Perucho M, Arnheim N (1990) Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50: 1279–1283
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Pour, P.M., Konishi, Y., Klöppel, G., Longnecker, D.S. (1994). Molecular Biology. In: Pour, P.M., Konishi, Y., Klöppel, G., Longnecker, D.S. (eds) Atlas of Exocrine Pancreatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68311-7_20
Download citation
DOI: https://doi.org/10.1007/978-4-431-68311-7_20
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68313-1
Online ISBN: 978-4-431-68311-7
eBook Packages: Springer Book Archive